10.3389/fphar.2021.632295 Summary Keywords gastric pentadecapeptide BPC 157, primary abdominal compartment syndrome, rats, brain edema, lung edema Citation Tepes M, Gojkovic S, Krezic I, Zizek H, Vranes H, Madzar Z, Santak G, Batelja L, Milavic M, Sikiric S, Kocman I, Simonji K, Samara M, Knezevic M, Barisic I, Lovric E, Strbe S, Kokot A, Sjekavica I, Kolak T, Skrtic A, Seiwerth S, Boban Blagaic A and Sikiric P (2021) Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats
The concentration, mg/mL, tells you how much mass is dissolved in a certain volume
It does not directly stimulate muscle growth the way anabolic hormones or growth hormone-releasing peptides are intended to
DHT Pathway Modulation Emerging research suggests GHK-Cu may modulate the 5-alpha reductase pathway that converts testosterone to DHT, potentially reducing the DHT-related follicle miniaturization at the heart of androgenetic alopecia
small aliquots stored at lower temperatures extend usable life
The most recent synthesis, a 2025 review by Sikiric and colleagues in Pharmaceuticals (Basel) , addresses BPC-157 as a modulator of angiogenesis and the nitric oxide system